Home » MERCK TO BUY GLYCOFI, ABMAXIS FOR $480M
MERCK TO BUY GLYCOFI, ABMAXIS FOR $480M
Pharmaceutical company Merck & Co. Inc. said Tuesday it agreed to acquire GlycoFi Inc., a privately held biotechnology company, for $400 million in cash.
Business Week (http://www.businessweek.com/ap/financialnews/D8HG9N485.htm?campaign_id=apn_home_down&chan=db)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May